MEGAN ROZELL: Open Payments
NPI 1679093439 · NEWCOMB, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 30 payments from 10 companies in 2025. Trend: 2023 $1,007 · 2024 $1,071 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $240 |
| ABBVIE INC. | 5 | $110 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Lilly USA, LLC | 3 | $49 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Amgen Inc. | 1 | $29 |
| PFIZER INC. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $17 |
Products named: VRAYLAR, Ozempic, Wegovy, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, CAPLYTA, OTEZLA.
Industry payments across NY — which companies pay providers there.
